Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL6012 Target Snapshot

Inhibitor of nuclear factor kappa-B kinase subunit beta · SINGLE PROTEIN · Mus musculus

45Compounds
34Assays
0Approved Drugs
27.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt O88351. Use UniProt O88351 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O88351 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Inhibitor of nuclear factor kappa-B kinase subunit beta as ChEMBL target CHEMBL6012, mapped to UniProt O88351. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Inhibitor of nuclear factor kappa-B kinase subunit beta
SINGLE PROTEIN · Mus musculus
As of 2026-09-14
ChEMBL target ID
CHEMBL6012
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
O88351
Inhibitor of nuclear factor kappa-B kinase subunit beta
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Inhibitor of nuclear factor kappa-B kinase subunit beta is the right protein anchor across sources, using UniProt O88351 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelInhibitor of nuclear factor kappa-B kinase subunit beta
UniProt AccessionO88351
Component TypeProtein
Sequence Length757 aa

Inhibitor of nuclear factor kappa-B kinase subunit beta

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Inhibitor of nuclear factor kappa-B kinase subunit beta, mapped to UniProt O88351. Sequence length is 757 aa.

Mapped IDO88351
Review nameInhibitor of nuclear factor kappa-B kinase subunit beta
OrganismMus musculus
Assay Mix

Activity Type Distribution

IC5027.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3765499 6.3 IC50 500.0 Preclinical
CHEMBL360077 5.75 IC50 1800.0 Preclinical
CHEMBL2070413 5.7 IC50 2000.0 Preclinical
CHEMBL3765155 5.7 IC50 2000.0 Preclinical
CHEMBL3764369 5.52 IC50 3000.0 Preclinical
CHEMBL2070414 5.4 IC50 4000.0 Preclinical
CHEMBL3764354 5.4 IC50 4000.0 Preclinical
CHEMBL3764955 5.4 IC50 4000.0 Preclinical
CHEMBL3765189 5.4 IC50 4000.0 Preclinical
CHEMBL2070412 5.3 IC50 5000.0 Preclinical
Distribution

pChEMBL Value Distribution

15
5.0
5
5.5
1
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

34
Total Assays
27
Tested Compounds
1
Assay Types
Binding — 34 assays, 27 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 30 14 5.1
tissue-based format 3 0
assay format 1 13 5.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine